Have you ever sifted through a mountain of health advice only to feel more lost than when you started?
That's where Dr. Elizabeth Yurth comes in—guiding us through aging research with her knowledgeable insights. In today’s episode, we discuss anti-aging medicine, the pitfalls of research bias, and the gender discrepancies that muddy the waters of scientific studies.
With a nod to John Ioannidis' work, we talk about the need for validating scientific claims. When theory meets practice, the truth can be surprising. We share firsthand experiences from clinical work, revealing how animal studies fare once they reach the human testing ground.
Overall, we explore the heart of longevity, where social connections and stress-free living are crucial.
Dr. Elizabeth Yurth is the Co-Founder and Chief Medical Officer of Boulder Longevity Institute, where she has been providing Tomorrow’s Medicine Today to her clients since 2006. Dr. Yurth has completed over 500 hours of Continuing Medical Education (CME) training in the areas of Longevity, Epigenetics, Nutrition, Bioidentical Hormone Replacement Therapy, Regenerative Peptide Treatments, and Regenerative Orthopedic Procedures.
Thank you to our sponsors for making this episode possible:
Quicksilver: Visit quicksilverscientific.com/nat and use code Nat for 10% off your first purchase of PushCatch® Liver Detox.
BiOptimizers: For Sleep Breakthrough use code bionat at checkout to save on your order at bioptimizers.com/bionat
Find more from Dr. Elizabeth Yurth:
Website: https://boulderlongevity.com/
Instagram: @boulderlongevityinstitute
Youtube: https://www.youtube.com/@boulderlongevityinstitutel5018
Find more from Nathalie:
YouTube: https://www.youtube.com/channel/UCmholC48MqRC50UffIZOMOQ
Join Nat’s Membership Community: https://www.natniddam.com/bsp-community
Sign up for Nats Newsletter: https://landing.mailerlite.com/webforms/landing/i7d5m0
Instagram: https://www.instagram.com/nathalieniddam/
Website: www.NatNiddam.com
Facebook Group: https://www.facebook.com/groups/biohackingsuperhumanperformance
What We Discuss:
(00:02) Navigating Aging Research and Recommendations
(07:22) Clinical Testing Ground for Longevity Drugs
(20:05) Benefits and Risks of Antioxidants
(31:42) Cycling Supplements and Aging Measurements
(35:47) Reevaluating Biological Aging and Longevity
(45:03) Low-Dose Naltrexone for Repurposed Medication
(54:56) Drug Repurposing for Various Health Conditions
(01:00:33) Weight Loss Drugs and Their Effects
(01:11:24) Cellular Health and Longevity Discussion
Key Takeaways:
-
Research findings should be critically evaluated, considering factors such as study design, reproducibility, and applicability to humans.
-
LDN can be effective in reducing cramps and arthritis symptoms by deactivating microglial cells.
-
Amlexanox is an underutilized drug with anti-allergic and anti-inflammatory properties.
-
Tessafensin, a triple uptake inhibitor, may aid in weight loss and improve cellular function.
LONGEVITY with Nathalie Niddam 